10 Regeneron business development leaders
These Regeneron business development leaders hold vice president, executive director, senior director and director titles in business development and strategic alliances, including therapeutic area and diagnostics business development roles. A reader can learn how business development leaders work at Regeneron from people who have held the role.
Professionals to explore
Andrew Hilmer
LinkedInExperience: Director | Strategic Alliances · Regeneron
Andrew Hilmer has been Director | Strategic Alliances at Regeneron since January 2025, and held Associate Director (2022–2025) and Sr. Manager (2020–2021) titles in Strategic Alliances there. Andrew Hilmer was Director | Business Development and Sales at Applied StemCell (2018–2020).
Bhawani Singh, Ph.D.
LinkedInExperience: Sr. Director of Business Development · Regeneron
Bhawani Singh has been Sr. Director of Business Development at Regeneron since January 2023, and was Director of Business Development there (2021–2023). Bhawani Singh was Director Of Business Development at AMARIN PHARMA INC (2019–2021) and Director, Global Markets Team, HIV and India at Clinton Health Access Initiative, Inc. (2014–2019).
Brendan McGuirk
LinkedInExperience: Director, Diagnostics Business Development · Regeneron
Brendan McGuirk has been Director, Diagnostics Business Development at Regeneron since April 2025. At Regeneron, Brendan McGuirk was also Director, Clinical Category Management - Companion Diagnostics (2023–2025) and Associate Director, Category Management - Companion Diagnostics and Laboratory (2019–2023).
Dov Hass
LinkedInExperience: Vice President, Head of Genetic Medicine Business Development · Regeneron
Dov Hass has been Vice President, Head of Genetic Medicine Business Development at Regeneron since January 2024. At Regeneron, Dov Hass was also Executive Director, Head of Genetic Medicine Business Development (2022–2023), Senior Director, Business Development (2020–2021) and Senior Director, Assistant General Counsel, Transactions and Corporate Law (2019–2020).
Jennifer North
LinkedInExperience: Executive Director, Business Development · Regeneron
Jennifer North has been Executive Director, Business Development at Regeneron since January 2024. At Regeneron, Jennifer North also held Senior Director (2022–2023), Director (2020–2021), Associate Director (2019) and Senior Manager (2016–2018) titles in Business Development.
Justin T. Malinowski
LinkedInExperience: Director, Strategic Alliances · Regeneron
Justin T. Malinowski has been Director, Strategic Alliances at Regeneron since December 2024, and was Associate Director, Strategic Alliances there (2022–2024). At Amgen, Justin T. Malinowski was Business Development Senior Manager - Alliance Management & Integration (2020–2022) and Business Performance Senior Manager (2019–2020).
Kalpana Gupta
LinkedInExperience: Head of Immunology, Infectious Diseases and Metabolism Partnering, Executive Director BD · Regeneron
Kalpana Gupta has been Head of Immunology, Infectious Diseases and Metabolism Partnering, Executive Director BD at Regeneron since December 2020. Kalpana Gupta was Senior Director Of Business Development (2017–2019) and Director Of Business Development (2014–2017) at Regeneron, and worked in the Pharmaceutical & Life Sciences Healthcare Advisory Practice at PwC (2012–2014).
Karen Rodriguez Lorenc
LinkedInExperience: Vice President Business Development, Therapeutic Area Lead Hemato-Oncology · Regeneron
Karen Rodriguez Lorenc has been Vice President Business Development, Therapeutic Area Lead Hemato-Oncology at Regeneron since February 2025, and was Vice President, Global Program Head, Hematology and Translational Sciences at Regeneron (2020–2025). At Novartis, Karen Rodriguez Lorenc was Executive Director, Global Program Clinical Head (2018–2020).
Stephen Fisk
LinkedInExperience: Director, Strategic Alliances · Regeneron
Stephen Fisk has been Director, Strategic Alliances at Regeneron since May 2021, the only work row the source lists. The profile describes a biotechnology and pharmaceutical background spanning discovery, development and commercialization, including drug launch, in-line marketing, account management and managing clinical programs and early stage discovery assets.
Thinh Nguyen Duc, Ph.D.
LinkedInExperience: Senior Director of Business Development · Regeneron
Thinh Nguyen Duc has been Senior Director of Business Development at Regeneron since January 2024, and was Director of Business Development there (2022–2024). Thinh Nguyen Duc held corporate strategy roles at Regeneron (2017–2022), listed as Manger Sr Manager Associate Director Director of Corporate Strategy, and was a Management Consultant at L.E.K. Consulting (2015–2017).
Choose the right perspective
Pick someone whose business development title names the therapeutic area or platform closest to your question, since several of these titles are organized that way. Pick someone from strategic alliances when your question is about running a partnership after it is signed rather than finding one.
Questions to take into the conversation
- 01How does a biotech business development group organize its search for outside programs by therapeutic area?
- 02What does strategic alliance management involve once a biotech signs a partnership?
- 03How does a business development team work with research and clinical teams when evaluating an outside asset?
Reaching Regeneron business development leaders
How can I contact one of these Regeneron business development leaders?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 1 company: Regeneron, based on profile data retrieved on October 26, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach Regeneron business development leaders?
You choose the offer, starting at $5 per person. The offer is what the person receives, and Instant Expert's fee is added on top, so a $100 offer costs you $125. The fee is 20% of what you pay. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
Can an AI agent ask one of these Regeneron business development leaders a question?
Yes. An agent with a USDC wallet on Base can ask one question without an Instant Expert account. It names the person, for example by the LinkedIn URL on this page, and pays per ask over x402 (HTTP 402). The person answers in writing or by voice note, and if nobody answers within 7 days, the payment goes back to the wallet automatically. Claude and ChatGPT can do the same through the Instant Expert connector: setup is at /docs/mcp for Claude and /docs/chatgpt for ChatGPT. x402 docs
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.